DatasetName,RAI14_S(11) RAI14_S(1266) RAI14_S(235) RAI14_S(261) RAI14_S(263) RAI14_S(271) RAI14_S(273) RAI14_S(278) RAI14_S(281) RAI14_S(284) RAI14_S(286) RAI14_S(289) RAI14_S(290) RAI14_S(292) RAI14_S(293) RAI14_S(296) RAI14_S(298) RAI14_S(300) RAI14_S(313) RAI14_S(317) RAI14_S(318) RAI14_S(320) RAI14_S(321) RAI14_S(327) RAI14_S(335) RAI14_S(340) RAI14_S(350) RAI14_S(355) RAI14_S(358) RAI14_S(374) RAI14_S(376) RAI14_S(386) RAI14_S(390) RAI14_S(405) RAI14_S(410) RAI14_S(411) RAI14_S(412) RAI14_S(414) RAI14_S(419) RAI14_S(422) RAI14_S(475) RAI14_S(512) RAI14_S(515) RAI14_S(518) RAI14_S(624) RAI14_S(638) RAI14_S(649) RAI14_S(666) RAI14_S(667) RAI14_S(795) RAI14_S(905) RAI14_S(915) RAI14_T(249) RAI14_T(251) RAI14_T(252) RAI14_T(266) RAI14_T(287) RAI14_T(292) RAI14_T(295) RAI14_T(297) RAI14_T(360) RAI14_T(361) RAI14_T(404) RAI14_T(472) RAI14_Y(519) RAI14_Y(576) RAI14_Y(583),RAI14_S(264) RAI14_S(274) RAI14_S(285) RAI14_S(306) RAI14_S(354) RAI14_S(357) RAI14_S(383) RAI14_S(478) RAI14_T(13) RAI14_T(283)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.532765045612997,0.3171826582931628
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.522592012320341,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5297872733261662,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5231813649312759,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.52376459815727,0.34295766996076293
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.518393580266021,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5189337725032576,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5222853619850698,
WZ2023_Pu_010_30min,0.5341448361849672,0.3303685129773816
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5191405792075294,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,0.5237216565337199,
AH2018_TMTMS3_1_C,0.5207962979922741,
JJ2018_Ratio H/L normalized___1,0.5246502792885887,
ZQ2022_C2,0.5270602994485792,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5241192507778576,
AH2018_SILAC_MR_2_N,0.5256389561232739,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.52786489094176,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.5274234989571381,0.3263282423435583
EP2017_Pervanadate R#3 normalized log2 ratio,0.5369596517968387,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5216449197942894,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.52370477568541,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5359202299413854,0.32197415214714864
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5312324496479125,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5300885041846988,0.32188123899338705
AH2018_SILAC_MR_2_X,0.5219262610163592,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5265252460039542,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5203892757957859,
JJ2018_Ratio M/L normalized pP3,0.5211045992169294,
AH2018_SILAC_M_2_N,0.5227130415849408,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5495525280278216,0.31036373542574064
AH2018_LFQ_1_C,0.5238613770103651,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5349224291750191,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5204593873606149,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.528375076066058,
FSO2013_Ratio H/L normalized Rep2,0.5239429780128101,0.30353357418643684
WZ2023_Pu_005_20min,0.5342806233922675,0.3262552497809585
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5270689094097939,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.5248871938373466,0.3176163417889724
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,
PG2020_Intensity Mock_10h_D,0.5211613828084417,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5123157358860162,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,0.5248321053997148,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5227574242397657,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5243911476972294,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5202019679958357,
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5293661431120859,
HH2022_Reporter intensity 8,0.5241073679042465,
ZQ2022_N2,0.5254781429458468,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5295996165470616,
EJN2021_5_Rest_Basal,0.5263389398381703,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5202569339525727,
YA2020_Reporter_intensity_Normal_No.1,0.5305269783054858,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5311285829633327,
HS2024_8_I_T3,,
CF2017_EOC 3,0.521083279383682,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5307741142339655,0.3242897338227324
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.5128192009632021,0.33291703477003326
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5251698166593377,
FSO2013_Ratio H/M normalized Rep2,0.5461663260066594,0.2980847287378007
RAM2015_Log2 A,0.529646521111449,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5285082234200994,
CF2017_OSE 27,0.5298122983141588,
KS2014_Intensity E15_2,0.5318245179874405,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5219315403567684,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5212969111227616,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5229234974783892,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5224143523558749,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5285437790819801,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5240141613653649,
FSO2013_Ratio M/L normalized Rep2,0.5367630749489515,0.3302476062902024
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5248260611670743,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.526391870174627,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5211022187204618,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5267891897434628,0.3278716542744521
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5276484763201233,
EJN2021_4_Rest_Ins,0.5266395319771182,
RN2012_H05,0.5221429270241911,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5291362626172508,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5262226769586592,
HH2022_Reporter intensity 3,0.5287545304042298,0.3225509403626832
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.522327469102735,
JW2021_After_3,,
GF2025_P8_Sph,0.5150360837891781,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5249872041900383,
AH2018_SILAC_2_N,0.5206814933505144,
CK2022_11 200-1,,
CK2022_12 200-1,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5265079150859275,
WZ2023_Su_010_20min,0.5332206752644936,0.32483841966574944
AH2018_TMTMS2_2_N,0.5242296409579933,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5342811766742345,
KS2014_Intensity N4,0.518194271404201,0.33103869485657966
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5258900460673014,
CK2022_14 200-1,,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5332007780399031,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5250512286471801,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5266404923326607,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.539003203445115,
GF2025_P1_Sph,0.5184802988816962,
EJN2021_5_Ex_Basal,0.5264491844895854,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5320964247337577,0.32292763604284
CF2017_EOC 1,0.5212742470838178,
CK2022_3 200-1,,
AH2018_LFQ_IT_3_C,0.5206143966832776,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5274809590565642,0.35693595861450744
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5266508076149828,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5406083932248071,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.525188490013867,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5317646859821837,0.32596839604485284
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5204551205859259,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5363563949550155,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.5227342825934133,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5266202976249076,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5315846436390608,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5228275569050593,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.5184896311706628,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5489623598807157,0.3002341780831076
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5251350122830303,
HH2022_Reporter intensity 6,0.5301124483696251,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5265534879086875,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5200364727496875,
GF2025_P3_Adh,0.5348684848812045,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5255052127131513,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5254358228159115,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.531846465358488,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5354763236149948,
LG2023_Control-2_intensity,0.5268302065889866,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5302090602599381,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.522984537393661,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5185590085382686,
HH2022_Reporter intensity 1,0.528723112741772,0.32361020245829286
HH2022_Reporter intensity 2,0.5288382535751323,0.3237408942849368
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5287734409396938,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5252172973879523,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5194295547075206,0.30562979774882304
AR2021_KD 72h,0.5274140771612896,0.3352803595843869
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5362049106606444,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,0.521355152821588,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5213514090129628,
CF2017_OSE 29,0.5241156398243375,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,0.33407973179195494
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5232788988704731,
RN2012_L12,0.5317661427634359,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5196232288787518,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5538270254683072,0.313681528072231
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.526197073777419,
TM2022_S2.12h.B,,
RN2012_L15,0.5100090254607227,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5266845033474157,
FSO2013_Ratio H/M normalized Rep2___2,0.5255428301933298,0.32200910537406013
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5249039804993667,0.3199017219420488
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,
CK2022_5 200-1,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5245992311791574,0.3028507957559274
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5253516935463144,
AH2018_SILAC_MR_1_X,0.5311429418373528,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5196302306887038,
EJN2021_5_Rest_Ins,0.5267124532813386,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5536268026284956,0.3120214305357315
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5262134150000584,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5268153392363134,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5266298090538831,
JJ2018_Ratio M/L normalized pP2,0.5249818065160308,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.525808356774494,
FSO2013_Ratio H/L normalized Rep3,0.5109526580080904,0.3135827436804225
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5215299746581288,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,0.5271386981074322,
AH2018_SILAC_IT_1_X,0.5283286843208641,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5234848137456682,
WZ2023_Pe_025_20min,0.538407563236856,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5216730256346033,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5208940278640494,
RN2012_H06,0.5123231749513794,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5313678435528126,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,0.5333167961699314,0.32207529767795284
AH2018_LFQ_IT_4_X,0.5203623294983406,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5332278296199828,0.3231557980229325
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5259536546307921,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5468351967438575,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.530830037386554,0.32970684366857406
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5239441522833583,
LY2019_P7+,0.5259872698736854,
EP2017_Untreated R#1 normalized log2 ratio,0.5402872825040494,
RN2012_L10,0.5260498423583824,
PG2020_Intensity 4h_C,0.5261837131169772,
EP2017_Mitotic R#3 normalized log2 ratio,0.5128306570557282,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5282437442983533,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5284901627779092,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5091912795406167,
GF2025_P9_Sph,0.5215979857517582,
CK2022_6 200-1,,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5382149829926476,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5222607046785145,
EP2017_Untreated R#3 normalized log2 ratio,0.5238701641458483,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5243339877651014,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5383622212327797,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5206118102977207,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.526178602694447,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5302460491378411,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5250571131485556,0.3613522236600856
PG2020_Intensity CT_C,0.5232497372698537,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5240494898137825,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5295799715080368,
YA2020_Reporter_intensity_Normal_No.2,0.5308795183291981,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5345024899817615,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.5279558681247397,
AH2018_LFQ_M_2_N,0.5213012688015163,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,0.5234116861828118,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5287605907666613,0.34356810121538095
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5267318449470683,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5273653429668237,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,0.3344675314017868
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5250504804381433,
WZ2023_Su_025_30min,0.5302777625784196,0.3237851154752113
AH2018_LFQ_4_N,0.5242269174851901,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5284147373972077,
AH2018_SILAC_M_1_X,0.5261469600358861,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5258478285905462,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5410504172189707,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5357891461472299,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5321007587138075,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5269869001169205,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5223005152536722,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5160741648211362,
AH2018_LFQ_2_X,0.5188524469608354,
PG2020_Intensity 2h_B,0.5238968383603029,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5299843713880388,
GF2025_P3_Sph,0.5214666598927987,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5226011278819246,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5268839964002107,0.33099491896016187
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5270971828385385,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5253333794935093,
CR2017_Ratio Replicate 2.4,,
ZQ2022_N1,0.5254167463768177,
LY2019_P6-,0.5265296633703789,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5132921295294373,
AH2018_LFQ_3_N,0.5204875050997636,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5246085052896345,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5227625862244477,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.523754135196236,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.52478824258175,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5322841295896792,0.3269813562769544
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5268681531979391,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.548958067533375,0.3083413734300759
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5269384874707619,
PG2020_Intensity 10h_D,0.5218431935871203,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.5266561720484062,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5264774387572504,
EP2017_Pervanadate R#3 log2 ratio,0.5369351388506726,
FSO2013_Ratio M/L normalized Rep1___3,0.529600709370949,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5284648698493228,
AH2018_LFQ_M_4_C,0.5166966870761254,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5272735634054637,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5257691254242152,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5263707401215059,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5322438956072421,0.3235692416352201
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5264377022128729,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5220762822595061,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5306036685228768,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5280309085780719,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,0.5296722065508525,
AH2018_TMTMS2_2_C,0.5261046159542193,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5344724839680165,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5263842078354861,
LY2019_P8+,0.5278691670415255,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.5297524139183645,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5225876236944419,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5275231802416617,
LY2019_P2-,0.5271948987057433,
AH2018_LFQ_IT_1_X,0.5249010762442673,
JJ2018_Ratio H/L normalized pP3___1,0.522725661410374,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5337166384778597,0.3203420459403294
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5282973076093201,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.5264101696269946,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5297616683336517,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5263050405336442,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5114617224953829,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5344687070433746,0.3220877782124113
KS2014_Intensity C2,0.5281611729039625,0.3174257682821368
FSO2013_Ratio H/L normalized Rep1___2,0.5299401073068969,0.33732355556763527
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5285778007475719,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.531904799364739,
ZQ2022_C3,0.5280075189605913,
EJN2021_3_Rest_Ins,0.5265561150725523,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,0.52495613762891,0.31807826519244725
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5404341482516543,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5314727265520199,0.32612756378968005
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.516995402968331,0.3253065032432071
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5274015193839987,
AH2018_SILAC_MR_2_C,0.5246683749795935,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.523617003459932,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5243453505442103,
JJ2018_Ratio H/M normalized___1,0.528818009513618,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5311916045985885,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5262255064822169,0.3401673543375022
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5323004846063522,0.3209831995407359
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5162637961169164,
AH2018_LFQ_IT_4_N,0.5202399333714177,
CK2022_15 200-1,,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5287904309180051,
JJ2018_Ratio M/L normalized pP3___1,0.5210695933456179,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5254645574442849,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5329287609877479,0.3263327569779146
RN2012_H01,0.5189495985110635,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5267855481703729,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5468189348553797,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5304601114377725,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.5337568012757418,0.32244262697249954
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.5211695765139883,0.3194557490847893
FSO2013_Ratio H/M normalized Rep3___1,0.5206829826911498,0.3053425008299308
AH2018_SILAC_M_3_C,0.5210165412345165,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5226142662086882,
AH2018_SILAC_M_2_X,0.5215453350620344,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5313389342484424,0.31745938922127703
PG2020_Intensity 6h_C,0.5254437049278274,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5252913749833596,
AH2018_LFQ_M_3_N,0.5219773177480572,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5242915945576423,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5274243754188577,
FSO2013_Ratio H/L normalized Rep3___2,0.5267605100032349,0.3288262950361556
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5287344877581325,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5356667093201072,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5060139276651074,
EJN2021_2_Ex_Basal,0.5267338512644396,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5279066169520105,
AR2021_L41 10 μM,0.5264565173279223,0.33991599360881464
CF2017_EOC 2,0.5187908453823467,0.2855066983535005
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5251796557502829,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,0.522643977259578,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5289435393125228,0.32381580692125944
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5224875930577599,
AR2021_L41 1 μM,0.5263048013058422,0.3460380973252125
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.523829535691418,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.522615458345179,
KS2014_Intensity C4,0.5271931030602004,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.5271602300244809,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5211590072583893,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5316797503510583,
FSO2013_Ratio H/M normalized Rep2___3,0.5288347446561636,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5236736174707772,
WZ2023_Pu_025_10min,0.5324650987725191,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5362699163758873,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5233231322997041,
JJ2018_Ratio H/L normalized pP1___1,0.5237818006140448,
WZ2023_Pe_010_30min,0.5329049150229128,0.31817317192448524
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5206714439357999,
KS2014_Intensity C6,0.5299045031335565,0.31168337220697556
ZQ2022_N3,0.5247798912022782,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5234090617679948,
JJ2018_Ratio H/M normalized pP1,0.5264217839854164,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5232053393918559,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5243005950076113,
UK2020_UA_3,,
LY2019_P7-,0.5244518995355444,
GF2025_P5_Adh,0.5356806722749594,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5114411729664929,0.31357729663592326
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,0.5280209270284252,
CR2017_Ratio Replicate 2.1,,
PG2020_Intensity CT_B,0.5217675368851471,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5274415601247262,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5262416701541609,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5224456862680527,
YA2020_Reporter_intensity_Cancer_No.4,0.5318847827144493,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5275204228731992,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5214798071010479,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.5271249977694566,0.3326096281341099
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5093265333530566,
AH2018_TMTMS2_1_X,0.5207767391252094,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5264151399834104,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.5216477905527812,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5266920722984207,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.524905810359641,
PG2020_Intensity 10h_B,0.5229593878703237,
AH2018_TMTMS3_1_X,0.535031795674848,
CF2017_FTE 14,0.5261313285288093,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5255614631605123,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5251123687775603,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5269314184044109,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5383335305231204,
AS2011_Ratio H/L Normalized RNAi_2_1,,
